These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
39 related articles for article (PubMed ID: 13596365)
1. A factorial experiment to study factors which reverse aminopterin inhibition. BIGGERS JD; WEBB M Biochem J; 1958 Nov; 70(3):487-9. PubMed ID: 13596365 [No Abstract] [Full Text] [Related]
2. Aminopterin inhibition in Aerobacter aerogenes; alanine and valine accumulation during the inhibition and their utilization on recovery. WEBB M Biochem J; 1958 Nov; 70(3):472-86. PubMed ID: 13596364 [No Abstract] [Full Text] [Related]
3. Attempted reversal of the diethylstilbestrol inhibition of substrate oxidation in Aerobacter aerogenes. DURHAM NN; PERRY MD Can J Biochem Physiol; 1959 Jun; 37(6):801-2. PubMed ID: 13651982 [No Abstract] [Full Text] [Related]
4. Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. Savini V; Catavitello C; Balbinot A; Talia M; Manna A; Febbo F; Pompilio A; Di Bonaventura G; Piccolomini R; D'Antonio D J Infect; 2008 Nov; 57(5):416-8. PubMed ID: 18835042 [No Abstract] [Full Text] [Related]
6. Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates. Ghisalberti D; Mahamoud A; Chevalier J; Baitiche M; Martino M; Pagès JM; Barbe J Int J Antimicrob Agents; 2006 Jun; 27(6):565-9. PubMed ID: 16707249 [TBL] [Abstract][Full Text] [Related]
7. Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. Dupont M; Dé E; Chollet R; Chevalier J; Pagès JM FEBS Lett; 2004 Jul; 569(1-3):27-30. PubMed ID: 15225603 [TBL] [Abstract][Full Text] [Related]
8. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-beta-lactamase VIM-1 in Greece. Galani I; Souli M; Koratzanis E; Koratzanis G; Chryssouli Z; Giamarellou H J Antimicrob Chemother; 2007 Mar; 59(3):578-9. PubMed ID: 17255145 [No Abstract] [Full Text] [Related]
9. Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Ghisalberti D; Masi M; Pagès JM; Chevalier J Biochem Biophys Res Commun; 2005 Mar; 328(4):1113-8. PubMed ID: 15707992 [TBL] [Abstract][Full Text] [Related]
10. Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants. Masi M; Pagès JM; Pradel E J Antimicrob Chemother; 2006 Jun; 57(6):1223-6. PubMed ID: 16606635 [TBL] [Abstract][Full Text] [Related]
11. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp]. Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641 [TBL] [Abstract][Full Text] [Related]
12. An unusual Gram stain finding. Chan-Tack KM; Johnson JK Clin Infect Dis; 2005 Jun; 40(11):1649, 1677-8. PubMed ID: 15895484 [No Abstract] [Full Text] [Related]
13. High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients. Goethaert K; Van Looveren M; Lammens C; Jansens H; Baraniak A; Gniadkowski M; Van Herck K; Jorens PG; Demey HE; Ieven M; Bossaert L; Goossens H Clin Microbiol Infect; 2006 Jan; 12(1):56-62. PubMed ID: 16460547 [TBL] [Abstract][Full Text] [Related]
14. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. Fernández-Cuenca F; Rodríguez-Martínez JM; Martínez-Martínez L; Pascual A Int J Antimicrob Agents; 2006 Jun; 27(6):549-52. PubMed ID: 16697150 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the bacteriological safety of wares made from different metals]. Levanova GF; Martynova IE Gig Sanit; 2006; (2):47-9. PubMed ID: 16758821 [TBL] [Abstract][Full Text] [Related]
17. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases. Chen YG; Zhang Y; Yu YS; Qu TT; Wei ZQ; Shen P; Li LJ Int J Antimicrob Agents; 2008 Oct; 32(4):302-7. PubMed ID: 18556176 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro antibacterial activities of cefetamet (Ro 15-8074/005), a new oral cephalosporin, and eight other oral antimicrobials. Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K J Chemother; 1989 Jul; 1(4 Suppl):119-22. PubMed ID: 16312332 [No Abstract] [Full Text] [Related]
19. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens. Park YJ; Yu JK; Lee S; Park JJ; Oh EJ Ann Clin Lab Sci; 2007; 37(1):75-8. PubMed ID: 17311873 [TBL] [Abstract][Full Text] [Related]
20. The endemic situation of Enterobacter aerogenes and Enterobacter cloacae: you will only discover what you are looking for. Vonberg RP; Wolter A; Kola A; Ziesing S; Gastmeier P J Hosp Infect; 2007 Apr; 65(4):372-4. PubMed ID: 17275960 [No Abstract] [Full Text] [Related] [Next] [New Search]